Bridgewater, NJ, United States of America

Mohit Atul Kothare

This inventor holds 15 USPTO granted patents and 7 published patent applications, plus 4 CIPO patents and 5 EPO patents. Top assignees: Signal Pharmaceuticals, Inc., Celgene Car LLC, Celgene Corporation. Active years: 2012-2023.

USPTO Granted Patents = 15 (Patent Applications = 7)

% Patents Active = 93.3

CIPO Patents = 4

EPO Patents = 5 (Patent Applications = 5)

Average Co-Inventor Count = 4.8

ph-index = 6

Forward Citations = 99(Granted Patents)

Company Filing History:

11 out of 169

Signal Pharmaceuticals, Inc.

Years Active: 2012-2023

Loading Chart...

15 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11655257 - MK2 inhibitors, synthesis thereof, and intermediates thereto (2023-05-23),

2. 11492332 - Isotopologues of 2-(tert-butylamino)-4-((1R,3R,4R)-3-hydroxy-4-methylcyclohexylamino)-pyrimidine-5-carboxamide (2022-11-08),

3. 11312699 - Processes for preparing 2-(4-chlorophenyl)-N-((2-(2,6-dioxopiperidin-3-yl)-1-oxoisoindolin-5-yl)methyl)-2,2-difluoroacetamide (2022-04-26),

4. 11241430 - Solid forms of 2-(tert-butylamino)-4-((1R,3R,4R)-3-hydroxy-4-methylcyclohexylamino)-pyrimidine-5-carboxamide, compositions thereof and methods of their use (2022-02-08),

5. 10975039 - Isotopologues of 2-(tert-butylamino)-4-((1R,3R,4R)-3-hydroxy-4-methylcyclohexylamino)-pyrimidine-5-carboxamide (2021-04-13),

6. 10894796 - MK2 inhibitors, synthesis thereof, and intermediates thereto (2021-01-19),

7. 10689351 - Isotopologues of 2-(tert butylamino)-4-((1R,3R,4R)-3-hydroxy-4-methylcyclohexylamino)-pyrimidine-5-carboxamide (2020-06-23),

8. 10517873 - Solid forms of 2-(tert-butylamino)-4-((1R,3R,4R)-3-hydroxy-4-methylcyclohexylamino)-pyrimidine-5-carboxamide, compositions thereof and methods of their use (2019-12-31),

9. 10226461 - Solid forms of 2-(tert-butylamino)-4-((1R,3R,4R)-3-hydroxy-4-methylcyclohexylamino)-pyrimidine-5-carboxamide, compositions thereof and methods of their use (2019-03-12),

10. 10189808 - Solid forms of 2-(4-chlorophenyl)-N-((2-(2,6-dioxopiperidin-3-yl)-1-oxoisoindolin-5-yl)methyl)-2,2-difluoroacetamide, and their pharmaceutical compositions and uses (2019-01-29),

11. 9814713 - Solid forms of 2-(tert-butylamino)-4-((1R,3R,4R)-3-hydroxy-4-methylcyclohexylamino)-pyrimidine-5-carboxamide, compositions thereof and methods of their use (2017-11-14),

12. 9365524 - Solid forms of 2-(tert-butylamino)-4-((1R,3R,4R)-3-hydroxy-4-methylcyclohexylamino)-pyrimidine-5-carboxamide, compositions thereof and methods of their use (2016-06-14),

13. 9079900 - Methods of synthesis and purification of heteroaryl compounds (2015-07-14),

14. 8569494 - Methods of synthesis and purification of heteroaryl compounds (2013-10-29),

15. 8158635 - [object Object] (2012-04-17),

Title: Mohit Atul Kothare - Pioneering Inventor from Bridgewater

Introduction: Mohit Atul Kothare is a distinguished inventor based in Bridgewater, NJ, known for his groundbreaking contributions to the field of technology and innovation.

Latest Patents: Mohit Atul Kothare holds several patents in the areas of artificial intelligence, machine learning, and robotics, showcasing his expertise in cutting-edge technologies.

Career Highlights: With a career spanning over two decades, Mohit Atul Kothare has worked with leading tech companies, spearheading projects that have revolutionized the industry.

Collaborations: Throughout his career, Mohit Atul Kothare has collaborated with top researchers, engineers, and scientists, fostering a culture of innovation and excellence in all his endeavors.

Conclusion: Mohit Atul Kothare's relentless pursuit of innovation and his passion for pushing the boundaries of technology make him a true visionary in the world of inventors.